Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Otaegui

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Plos One|March 4, 2014
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progressionHaritz Irizar, Maider Muñoz-Culla, Lucia Sepúlveda, et al.
Microorganisms|May 25, 2024
Bacteria-Fungi Interactions in Multiple SclerosisMiriam Gorostidi-Aicua, Iraia Reparaz, Ane Otaegui-Chivite, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)Javier Ruiz-Martínez, Ana Gorostidi, Berta Ibañez, et al.
Plos One|April 7, 2021
O group is a protective factor for COVID19 in Basque populationMaider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2011
HLA-DRB1*15:01 and multiple sclerosis: a female association?Haritz Irizar, Maider Muñoz-Culla, Olaia Zuriarrain, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2024
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control studyLaura Moles, Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, et al.
Frontiers in Immunology|November 3, 2022
Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosisLaura Moles, Susana Delgado, Miriam Gorostidi-Aicua, et al.
Frontiers in Immunology|August 12, 2025
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progressionAne Otaegui-Chivite, Miriam Gorostidi-Aicua, Laura Martins-Almeida, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 2, 2025
Resistance Exercise Intervention Restores Functional Capacity and Improves Frailty Biomarkers in CentenariansDiego Marcos-Perez, Adrián Hernandez-Vicente, Sara Cruces-Salguero, et al.
Frontiers in Aging|March 2, 2023
Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infectionLarraitz Aragon, Andrea Iribarren-López, Ainhoa Alberro, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Plos One|March 4, 2014
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progressionHaritz Irizar, Maider Muñoz-Culla, Lucia Sepúlveda, et al.
Microorganisms|May 25, 2024
Bacteria-Fungi Interactions in Multiple SclerosisMiriam Gorostidi-Aicua, Iraia Reparaz, Ane Otaegui-Chivite, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)Javier Ruiz-Martínez, Ana Gorostidi, Berta Ibañez, et al.
Plos One|April 7, 2021
O group is a protective factor for COVID19 in Basque populationMaider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2011
HLA-DRB1*15:01 and multiple sclerosis: a female association?Haritz Irizar, Maider Muñoz-Culla, Olaia Zuriarrain, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2024
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control studyLaura Moles, Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, et al.
Frontiers in Immunology|November 3, 2022
Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosisLaura Moles, Susana Delgado, Miriam Gorostidi-Aicua, et al.
Frontiers in Immunology|August 12, 2025
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progressionAne Otaegui-Chivite, Miriam Gorostidi-Aicua, Laura Martins-Almeida, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 2, 2025
Resistance Exercise Intervention Restores Functional Capacity and Improves Frailty Biomarkers in CentenariansDiego Marcos-Perez, Adrián Hernandez-Vicente, Sara Cruces-Salguero, et al.
Frontiers in Aging|March 2, 2023
Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infectionLarraitz Aragon, Andrea Iribarren-López, Ainhoa Alberro, et al.
Pageof 9